{"transactions":[{"id":741345,"issuer":{"id":6839,"kind":"organization","name":"Aldeyra Therapeutics, Inc."},"owners":[{"id":39188,"kind":"person","name":"Bronstein Ben","position":1,"cik":"0001604458","reported_name":"Bronstein Ben","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-11T20:20:49.000Z","date":"2026-06-09","kind":"grant","planned":false,"acquired":true,"shares":4977,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Exercisable with respect to 100% of the shares on the one-year anniversary of the grant date, provided that the Reporting Person provides continuous service as a member of the Audit Committee of the Board of Directors of the Issuer through the applicable vesting date."}],"balance_after":4977,"derivative":{"exercise_price":1.72,"expiration_date":"2036-06-08","underlying":"Common Stock","underlying_shares":4977},"source":{"system":"sec-edgar","filing":"0001193125-26-267600","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1341235/000119312526267600/ownership.xml","form_type":"4"}},{"id":741344,"issuer":{"id":6839,"kind":"organization","name":"Aldeyra Therapeutics, Inc."},"owners":[{"id":39188,"kind":"person","name":"Bronstein Ben","position":1,"cik":"0001604458","reported_name":"Bronstein Ben","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-11T20:20:49.000Z","date":"2026-06-09","kind":"grant","planned":false,"acquired":true,"shares":5309,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Exercisable with respect to 100% of the shares on the one-year anniversary of the grant date, provided that the Reporting Person provides continuous service as a member of the Nominating/Corporate Governance Committee of the Board of Directors of the Issuer through the applicable vesting date."}],"balance_after":5309,"derivative":{"exercise_price":1.72,"expiration_date":"2036-06-08","underlying":"Common Stock","underlying_shares":5309},"source":{"system":"sec-edgar","filing":"0001193125-26-267600","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1341235/000119312526267600/ownership.xml","form_type":"4"}},{"id":741343,"issuer":{"id":6839,"kind":"organization","name":"Aldeyra Therapeutics, Inc."},"owners":[{"id":39188,"kind":"person","name":"Bronstein Ben","position":1,"cik":"0001604458","reported_name":"Bronstein Ben","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-11T20:20:49.000Z","date":"2026-06-09","kind":"grant","planned":false,"acquired":true,"shares":70000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Exercisable with respect to 100% of the shares on the one-year anniversary of the grant date, provided that the Reporting Person provides continuous service as a member of the Board of Directors of the Issuer through the applicable vesting date."}],"balance_after":70000,"derivative":{"exercise_price":1.72,"expiration_date":"2036-06-08","underlying":"Common Stock","underlying_shares":70000},"source":{"system":"sec-edgar","filing":"0001193125-26-267600","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1341235/000119312526267600/ownership.xml","form_type":"4"}},{"id":1113009,"issuer":{"id":6839,"kind":"organization","name":"Aldeyra Therapeutics, Inc."},"owners":[{"id":39188,"kind":"person","name":"Bronstein Ben","position":1,"cik":"0001604458","reported_name":"Bronstein Ben","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-12T20:29:02.000Z","date":"2024-06-10","kind":"grant","planned":false,"acquired":true,"shares":3860,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Exercisable with respect to 100% of the shares on the one-year anniversary of the grant date, provided that the Reporting Person provides continuous service as a member of the Nominating/Corporate Governance Committee of the Board of Directors of the Issuer through the applicable vesting date."}],"balance_after":3860,"derivative":{"exercise_price":2.685,"expiration_date":"2035-06-09","underlying":"Common Stock","underlying_shares":3860},"source":{"system":"sec-edgar","filing":"0000950170-25-085454","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1341235/000095017025085454/ownership.xml","form_type":"4"}},{"id":1113008,"issuer":{"id":6839,"kind":"organization","name":"Aldeyra Therapeutics, Inc."},"owners":[{"id":39188,"kind":"person","name":"Bronstein Ben","position":1,"cik":"0001604458","reported_name":"Bronstein Ben","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-12T20:29:02.000Z","date":"2025-06-10","kind":"grant","planned":false,"acquired":true,"shares":3619,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Exercisable with respect to 100% of the shares on the one-year anniversary of the grant date, provided that the Reporting Person provides continuous service as a member of the Audit Committee of the Board of Directors of the Issuer through the applicable vesting date."}],"balance_after":3619,"derivative":{"exercise_price":2.685,"expiration_date":"2035-06-09","underlying":"Common Stock","underlying_shares":3619},"source":{"system":"sec-edgar","filing":"0000950170-25-085454","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1341235/000095017025085454/ownership.xml","form_type":"4"}},{"id":1113007,"issuer":{"id":6839,"kind":"organization","name":"Aldeyra Therapeutics, Inc."},"owners":[{"id":39188,"kind":"person","name":"Bronstein Ben","position":1,"cik":"0001604458","reported_name":"Bronstein Ben","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-12T20:29:02.000Z","date":"2025-06-10","kind":"grant","planned":false,"acquired":true,"shares":62728,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Exercisable with respect to 100% of the shares on the one-year anniversary of the grant date, provided that the Reporting Person provides continuous service as a member of the Board of Directors of the Issuer through the applicable vesting date."}],"balance_after":62728,"derivative":{"exercise_price":2.685,"expiration_date":"2035-06-09","underlying":"Common Stock","underlying_shares":62728},"source":{"system":"sec-edgar","filing":"0000950170-25-085454","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1341235/000095017025085454/ownership.xml","form_type":"4"}},{"id":1488144,"issuer":{"id":6839,"kind":"organization","name":"Aldeyra Therapeutics, Inc."},"owners":[{"id":39188,"kind":"person","name":"Bronstein Ben","position":1,"cik":"0001604458","reported_name":"Bronstein Ben","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-06T20:12:09.000Z","date":"2024-06-04","kind":"grant","planned":false,"acquired":true,"shares":2778,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Exercisable with respect to 100% of the shares on the one-year anniversary of the grant date, provided that the Reporting Person provides continuous service as a member of the Nominating/Corporate Governance Committee of the Board of Directors of the Issuer through the applicable vesting date."}],"balance_after":2778,"derivative":{"exercise_price":4.09,"expiration_date":"2034-06-03","underlying":"Common Stock","underlying_shares":2778},"source":{"system":"sec-edgar","filing":"0000950170-24-069885","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1341235/000095017024069885/ownership.xml","form_type":"4"}},{"id":1488143,"issuer":{"id":6839,"kind":"organization","name":"Aldeyra Therapeutics, Inc."},"owners":[{"id":39188,"kind":"person","name":"Bronstein Ben","position":1,"cik":"0001604458","reported_name":"Bronstein Ben","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-06T20:12:09.000Z","date":"2024-06-04","kind":"grant","planned":false,"acquired":true,"shares":2604,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Exercisable with respect to 100% of the shares on the one-year anniversary of the grant date, provided that the Reporting Person provides continuous service as a member of the Audit Committee of the Board of Directors of the Issuer through the applicable vesting date."}],"balance_after":2604,"derivative":{"exercise_price":4.09,"expiration_date":"2034-06-03","underlying":"Common Stock","underlying_shares":2604},"source":{"system":"sec-edgar","filing":"0000950170-24-069885","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1341235/000095017024069885/ownership.xml","form_type":"4"}},{"id":1488142,"issuer":{"id":6839,"kind":"organization","name":"Aldeyra Therapeutics, Inc."},"owners":[{"id":39188,"kind":"person","name":"Bronstein Ben","position":1,"cik":"0001604458","reported_name":"Bronstein Ben","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-06T20:12:09.000Z","date":"2024-06-04","kind":"grant","planned":false,"acquired":true,"shares":40282,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Exercisable with respect to 100% of the shares on the one-year anniversary of the grant date, provided that the Reporting Person provides continuous service as a member of the Board of Directors of the Issuer through the applicable vesting date."}],"balance_after":40282,"derivative":{"exercise_price":4.09,"expiration_date":"2034-06-03","underlying":"Common Stock","underlying_shares":40282},"source":{"system":"sec-edgar","filing":"0000950170-24-069885","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1341235/000095017024069885/ownership.xml","form_type":"4"}},{"id":1835429,"issuer":{"id":6839,"kind":"organization","name":"Aldeyra Therapeutics, Inc."},"owners":[{"id":39188,"kind":"person","name":"Bronstein Ben","position":1,"cik":"0001604458","reported_name":"Bronstein Ben","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-07-05T21:34:59.000Z","date":"2023-06-30","kind":"grant","planned":false,"acquired":true,"shares":1464,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Exercisable with respect to 100% of the shares on the one-year anniversary of the grant date, provided that the Reporting Person provides continuous service as a member of the Nominating/Corporate Governance Committee of the Board of Directors of the Issuer through the applicable vesting date."}],"balance_after":1464,"derivative":{"exercise_price":8.39,"expiration_date":"2033-06-29","underlying":"Common Stock","underlying_shares":1464},"source":{"system":"sec-edgar","filing":"0000950170-23-031781","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1341235/000095017023031781/ownership.xml","form_type":"4"}},{"id":1835428,"issuer":{"id":6839,"kind":"organization","name":"Aldeyra Therapeutics, Inc."},"owners":[{"id":39188,"kind":"person","name":"Bronstein Ben","position":1,"cik":"0001604458","reported_name":"Bronstein Ben","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-07-05T21:34:59.000Z","date":"2023-06-30","kind":"grant","planned":false,"acquired":true,"shares":1372,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Exercisable with respect to 100% of the shares on the one-year anniversary of the grant date, provided that the Reporting Person provides continuous service as a member of the Audit Committee of the Board of Directors of the Issuer through the applicable vesting date."}],"balance_after":1372,"derivative":{"exercise_price":8.39,"expiration_date":"2033-06-29","underlying":"Common Stock","underlying_shares":1372},"source":{"system":"sec-edgar","filing":"0000950170-23-031781","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1341235/000095017023031781/ownership.xml","form_type":"4"}},{"id":1835427,"issuer":{"id":6839,"kind":"organization","name":"Aldeyra Therapeutics, Inc."},"owners":[{"id":39188,"kind":"person","name":"Bronstein Ben","position":1,"cik":"0001604458","reported_name":"Bronstein Ben","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-07-05T21:34:59.000Z","date":"2023-06-30","kind":"grant","planned":false,"acquired":true,"shares":21222,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Exercisable with respect to 100% of the shares on the one-year anniversary of the grant date, provided that the Reporting Person provides continuous service as a member of the Board of Directors of the Issuer through the applicable vesting date."}],"balance_after":21222,"derivative":{"exercise_price":8.39,"expiration_date":"2033-06-29","underlying":"Common Stock","underlying_shares":21222},"source":{"system":"sec-edgar","filing":"0000950170-23-031781","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1341235/000095017023031781/ownership.xml","form_type":"4"}},{"id":1841862,"issuer":{"id":6839,"kind":"organization","name":"Aldeyra Therapeutics, Inc."},"owners":[{"id":39188,"kind":"person","name":"Bronstein Ben","position":1,"cik":"0001604458","reported_name":"Bronstein Ben","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-29T20:23:44.000Z","date":"2023-06-27","kind":"exercise","planned":false,"acquired":true,"shares":9604,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option is fully vested."}],"balance_after":0,"derivative":{"exercise_price":0.552,"expiration_date":"2023-09-07","underlying":"Common Stock","underlying_shares":9604},"source":{"system":"sec-edgar","filing":"0000899243-23-016709","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1341235/000089924323016709/doc4.xml","form_type":"4"}},{"id":1841861,"issuer":{"id":6839,"kind":"organization","name":"Aldeyra Therapeutics, Inc."},"owners":[{"id":39188,"kind":"person","name":"Bronstein Ben","position":1,"cik":"0001604458","reported_name":"Bronstein Ben","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-06-29T20:23:44.000Z","date":"2023-06-27","kind":"exercise","planned":false,"acquired":true,"shares":9604,"price":0.552,"value":5301.408,"ownership":{"direct":true},"balance_after":28248,"source":{"system":"sec-edgar","filing":"0000899243-23-016709","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1341235/000089924323016709/doc4.xml","form_type":"4"}},{"id":2237416,"issuer":{"id":6839,"kind":"organization","name":"Aldeyra Therapeutics, Inc."},"owners":[{"id":39188,"kind":"person","name":"Bronstein Ben","position":1,"cik":"0001604458","reported_name":"Bronstein Ben","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-09T21:06:12.000Z","date":"2022-06-07","kind":"grant","acquired":true,"shares":3711,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Exercisable with respect to 100% of the shares on the one-year anniversary of the grant date, provided that the Reporting Person provides continuous service as a member of the Nominating/Corporate Governance Committee of the Board of Directors of the Issuer through the applicable vesting date."}],"balance_after":3711,"derivative":{"exercise_price":3.6,"expiration_date":"2032-06-06","underlying":"Common Stock","underlying_shares":3711},"source":{"system":"sec-edgar","filing":"0000899243-22-021632","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1341235/000089924322021632/doc4.xml","form_type":"4"}},{"id":2237415,"issuer":{"id":6839,"kind":"organization","name":"Aldeyra Therapeutics, Inc."},"owners":[{"id":39188,"kind":"person","name":"Bronstein Ben","position":1,"cik":"0001604458","reported_name":"Bronstein Ben","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-09T21:06:12.000Z","date":"2022-06-07","kind":"grant","acquired":true,"shares":3479,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Exercisable with respect to 100% of the shares on the one-year anniversary of the grant date, provided that the Reporting Person provides continuous service as a member of the Audit Committee of the Board of Directors of the Issuer through the applicable vesting date."}],"balance_after":3479,"derivative":{"exercise_price":3.6,"expiration_date":"2032-06-06","underlying":"Common Stock","underlying_shares":3479},"source":{"system":"sec-edgar","filing":"0000899243-22-021632","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1341235/000089924322021632/doc4.xml","form_type":"4"}},{"id":2237414,"issuer":{"id":6839,"kind":"organization","name":"Aldeyra Therapeutics, Inc."},"owners":[{"id":39188,"kind":"person","name":"Bronstein Ben","position":1,"cik":"0001604458","reported_name":"Bronstein Ben","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-09T21:06:12.000Z","date":"2022-06-07","kind":"grant","acquired":true,"shares":53812,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Exercisable with respect to 100% of the shares on the one-year anniversary of the grant date, provided that the Reporting Person provides continuous service as a member of the Board of Directors of the Issuer through the applicable vesting date."}],"balance_after":53812,"derivative":{"exercise_price":3.6,"expiration_date":"2032-06-06","underlying":"Common Stock","underlying_shares":53812},"source":{"system":"sec-edgar","filing":"0000899243-22-021632","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1341235/000089924322021632/doc4.xml","form_type":"4"}},{"id":2673540,"issuer":{"id":6839,"kind":"organization","name":"Aldeyra Therapeutics, Inc."},"owners":[{"id":39188,"kind":"person","name":"Bronstein Ben","position":1,"cik":"0001604458","reported_name":"Bronstein Ben","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-10T21:44:58.000Z","date":"2021-06-08","kind":"grant","acquired":true,"shares":933,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Exercisable with respect to 100% of the shares on the one-year anniversary of the grant date, provided that the Reporting Person provides continuous service as a member of the Nominating/Corporate Governance Committee of the Board of Directors of the Issuer through the applicable vesting date."}],"balance_after":933,"derivative":{"exercise_price":12.97,"expiration_date":"2031-06-07","underlying":"Common Stock","underlying_shares":933},"source":{"system":"sec-edgar","filing":"0000899243-21-023007","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1341235/000089924321023007/doc4.xml","form_type":"4"}},{"id":2673539,"issuer":{"id":6839,"kind":"organization","name":"Aldeyra Therapeutics, Inc."},"owners":[{"id":39188,"kind":"person","name":"Bronstein Ben","position":1,"cik":"0001604458","reported_name":"Bronstein Ben","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-10T21:44:58.000Z","date":"2021-06-08","kind":"grant","acquired":true,"shares":875,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Exercisable with respect to 100% of the shares on the one-year anniversary of the grant date, provided that the Reporting Person provides continuous service as a member of the Audit Committee of the Board of Directors of the Issuer through the applicable vesting date."}],"balance_after":875,"derivative":{"exercise_price":12.97,"expiration_date":"2031-06-07","underlying":"Common Stock","underlying_shares":875},"source":{"system":"sec-edgar","filing":"0000899243-21-023007","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1341235/000089924321023007/doc4.xml","form_type":"4"}},{"id":2673538,"issuer":{"id":6839,"kind":"organization","name":"Aldeyra Therapeutics, Inc."},"owners":[{"id":39188,"kind":"person","name":"Bronstein Ben","position":1,"cik":"0001604458","reported_name":"Bronstein Ben","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-10T21:44:58.000Z","date":"2021-06-08","kind":"grant","acquired":true,"shares":13534,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Exercisable with respect to 100% of the shares on the one-year anniversary of the grant date, provided that the Reporting Person provides continuous service as a member of the Board of Directors of the Issuer through the applicable vesting date."}],"balance_after":13534,"derivative":{"exercise_price":12.97,"expiration_date":"2031-06-07","underlying":"Common Stock","underlying_shares":13534},"source":{"system":"sec-edgar","filing":"0000899243-21-023007","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1341235/000089924321023007/doc4.xml","form_type":"4"}},{"id":3113100,"issuer":{"id":6839,"kind":"organization","name":"Aldeyra Therapeutics, Inc."},"owners":[{"id":39188,"kind":"person","name":"Bronstein Ben","position":1,"cik":"0001604458","reported_name":"Bronstein Ben","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-06-11T21:51:59.000Z","date":"2020-06-09","kind":"grant","acquired":true,"shares":1541,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Exercisable with respect to 100% of the shares on the one-year anniversary of the grant date, provided that the Reporting Person provides continuous service as a member of the Compensation Committee of the Board of Directors of the Issuer through the applicable vesting date."}],"balance_after":1541,"derivative":{"exercise_price":5.02,"expiration_date":"2030-06-08","underlying":"Common Stock","underlying_shares":1541},"source":{"system":"sec-edgar","filing":"0000899243-20-016185","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1341235/000089924320016185/doc4.xml","form_type":"4"}},{"id":3113099,"issuer":{"id":6839,"kind":"organization","name":"Aldeyra Therapeutics, Inc."},"owners":[{"id":39188,"kind":"person","name":"Bronstein Ben","position":1,"cik":"0001604458","reported_name":"Bronstein Ben","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-06-11T21:51:59.000Z","date":"2020-06-09","kind":"grant","acquired":true,"shares":2311,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Exercisable with respect to 100% of the shares on the one-year anniversary of the grant date, provided that the Reporting Person provides continuous service as a member of the Audit Committee of the Board of Directors of the Issuer through the applicable vesting date."}],"balance_after":2311,"derivative":{"exercise_price":5.02,"expiration_date":"2030-06-08","underlying":"Common Stock","underlying_shares":2311},"source":{"system":"sec-edgar","filing":"0000899243-20-016185","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1341235/000089924320016185/doc4.xml","form_type":"4"}},{"id":3113098,"issuer":{"id":6839,"kind":"organization","name":"Aldeyra Therapeutics, Inc."},"owners":[{"id":39188,"kind":"person","name":"Bronstein Ben","position":1,"cik":"0001604458","reported_name":"Bronstein Ben","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-06-11T21:51:59.000Z","date":"2020-06-09","kind":"grant","acquired":true,"shares":26503,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Exercisable with respect to 100% of the shares on the one-year anniversary of the grant date, provided that the Reporting Person provides continuous service as a member of the Board of Directors of the Issuer through the applicable vesting date."}],"balance_after":26503,"derivative":{"exercise_price":5.02,"expiration_date":"2030-06-08","underlying":"Common Stock","underlying_shares":26503},"source":{"system":"sec-edgar","filing":"0000899243-20-016185","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1341235/000089924320016185/doc4.xml","form_type":"4"}},{"id":3409738,"issuer":{"id":6839,"kind":"organization","name":"Aldeyra Therapeutics, Inc."},"owners":[{"id":39188,"kind":"person","name":"Bronstein Ben","position":1,"cik":"0001604458","reported_name":"Bronstein Ben","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-09-19T20:23:26.000Z","date":"2019-09-17","kind":"purchase","acquired":true,"shares":1700,"price":5.85,"value":9945.0,"ownership":{"direct":true},"balance_after":18644,"source":{"system":"sec-edgar","filing":"0000899243-19-023923","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1341235/000089924319023923/doc4.xml","form_type":"4"}},{"id":3498538,"issuer":{"id":6839,"kind":"organization","name":"Aldeyra Therapeutics, Inc."},"owners":[{"id":39188,"kind":"person","name":"Bronstein Ben","position":1,"cik":"0001604458","reported_name":"Bronstein Ben","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2019-06-06T21:41:07.000Z","date":"2019-06-04","kind":"grant","acquired":true,"shares":1102,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Exercisable with respect to 100% of the shares on the one-year anniversary of the grant date, provided that the Reporting Person provides continuous service as a member of the Compensation Committee of the Board of Directors of the Issuer through the applicable vesting date."}],"balance_after":1102,"derivative":{"exercise_price":7.06,"expiration_date":"2029-06-03","underlying":"Common Stock","underlying_shares":1102},"source":{"system":"sec-edgar","filing":"0000899243-19-015824","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1341235/000089924319015824/doc4.xml","form_type":"4"}},{"id":3498537,"issuer":{"id":6839,"kind":"organization","name":"Aldeyra Therapeutics, Inc."},"owners":[{"id":39188,"kind":"person","name":"Bronstein Ben","position":1,"cik":"0001604458","reported_name":"Bronstein Ben","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2019-06-06T21:41:07.000Z","date":"2019-06-04","kind":"grant","acquired":true,"shares":1653,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Exercisable with respect to 100% of the shares on the one-year anniversary of the grant date, provided that the Reporting Person provides continuous service as a member of the Audit Committee of the Board of Directors of the Issuer through the applicable vesting date."}],"balance_after":1653,"derivative":{"exercise_price":7.06,"expiration_date":"2029-06-03","underlying":"Common Stock","underlying_shares":1653},"source":{"system":"sec-edgar","filing":"0000899243-19-015824","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1341235/000089924319015824/doc4.xml","form_type":"4"}},{"id":3498536,"issuer":{"id":6839,"kind":"organization","name":"Aldeyra Therapeutics, Inc."},"owners":[{"id":39188,"kind":"person","name":"Bronstein Ben","position":1,"cik":"0001604458","reported_name":"Bronstein Ben","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2019-06-06T21:41:07.000Z","date":"2019-06-04","kind":"grant","acquired":true,"shares":18951,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Exercisable with respect to 100% of the shares on the one-year anniversary of the grant date, provided that the Reporting Person provides continuous service as a member of the Board of Directors of the Issuer through the applicable vesting date."}],"balance_after":18951,"derivative":{"exercise_price":7.06,"expiration_date":"2029-06-03","underlying":"Common Stock","underlying_shares":18951},"source":{"system":"sec-edgar","filing":"0000899243-19-015824","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1341235/000089924319015824/doc4.xml","form_type":"4"}},{"id":3899643,"issuer":{"id":6839,"kind":"organization","name":"Aldeyra Therapeutics, Inc."},"owners":[{"id":39188,"kind":"person","name":"Bronstein Ben","position":1,"cik":"0001604458","reported_name":"Bronstein Ben","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2018-06-08T20:38:26.000Z","date":"2018-06-07","kind":"grant","acquired":true,"shares":903,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Exercisable with respect to 100% of the shares on the one-year anniversary of the grant date, provided that the Reporting Person provides continuous service as a member of the Compensation Committee of the Board of Directors of the Issuer through the applicable vesting date."}],"balance_after":903,"derivative":{"exercise_price":8.35,"expiration_date":"2028-06-06","underlying":"Common Stock","underlying_shares":903},"source":{"system":"sec-edgar","filing":"0000899243-18-015771","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1341235/000089924318015771/doc4.xml","form_type":"4"}},{"id":3899642,"issuer":{"id":6839,"kind":"organization","name":"Aldeyra Therapeutics, Inc."},"owners":[{"id":39188,"kind":"person","name":"Bronstein Ben","position":1,"cik":"0001604458","reported_name":"Bronstein Ben","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2018-06-08T20:38:26.000Z","date":"2018-06-07","kind":"grant","acquired":true,"shares":1354,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Exercisable with respect to 100% of the shares on the one-year anniversary of the grant date, provided that the Reporting Person provides continuous service as a member of the Audit Committee of the Board of Directors of the Issuer through the applicable vesting date."}],"balance_after":1354,"derivative":{"exercise_price":8.35,"expiration_date":"2028-06-06","underlying":"Common Stock","underlying_shares":1354},"source":{"system":"sec-edgar","filing":"0000899243-18-015771","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1341235/000089924318015771/doc4.xml","form_type":"4"}},{"id":3899641,"issuer":{"id":6839,"kind":"organization","name":"Aldeyra Therapeutics, Inc."},"owners":[{"id":39188,"kind":"person","name":"Bronstein Ben","position":1,"cik":"0001604458","reported_name":"Bronstein Ben","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2018-06-08T20:38:26.000Z","date":"2018-06-07","kind":"grant","acquired":true,"shares":15526,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Exercisable with respect to 100% of the shares on the one-year anniversary of the grant date, provided that the Reporting Person provides continuous service as a member of the Board of Directors of the Issuer through the applicable vesting date."}],"balance_after":15526,"derivative":{"exercise_price":8.35,"expiration_date":"2028-06-06","underlying":"Common Stock","underlying_shares":15526},"source":{"system":"sec-edgar","filing":"0000899243-18-015771","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1341235/000089924318015771/doc4.xml","form_type":"4"}},{"id":4285203,"issuer":{"id":6839,"kind":"organization","name":"Aldeyra Therapeutics, Inc."},"owners":[{"id":39188,"kind":"person","name":"Bronstein Ben","position":1,"cik":"0001604458","reported_name":"Bronstein Ben","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2017-06-12T21:07:19.000Z","date":"2017-06-08","kind":"grant","acquired":true,"shares":1481,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Exercisable with respect to 100% of the shares on the one-year anniversary of the grant date, provided that the Reporting Person provides continuous service as a member of the Compensation Committee of the Board of Directors of the Issuer through the applicable vesting date."}],"balance_after":1481,"derivative":{"exercise_price":5.15,"expiration_date":"2027-06-07","underlying":"Common Stock","underlying_shares":1481},"source":{"system":"sec-edgar","filing":"0000899243-17-016105","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1341235/000089924317016105/doc4.xml","form_type":"4"}},{"id":4285202,"issuer":{"id":6839,"kind":"organization","name":"Aldeyra Therapeutics, Inc."},"owners":[{"id":39188,"kind":"person","name":"Bronstein Ben","position":1,"cik":"0001604458","reported_name":"Bronstein Ben","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2017-06-12T21:07:19.000Z","date":"2017-06-08","kind":"grant","acquired":true,"shares":2222,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Exercisable with respect to 100% of the shares on the one-year anniversary of the grant date, provided that the Reporting Person provides continuous service as a member of the Audit Committee of the Board of Directors of the Issuer through the applicable vesting date."}],"balance_after":2222,"derivative":{"exercise_price":5.15,"expiration_date":"2027-06-07","underlying":"Common Stock","underlying_shares":2222},"source":{"system":"sec-edgar","filing":"0000899243-17-016105","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1341235/000089924317016105/doc4.xml","form_type":"4"}},{"id":4285201,"issuer":{"id":6839,"kind":"organization","name":"Aldeyra Therapeutics, Inc."},"owners":[{"id":39188,"kind":"person","name":"Bronstein Ben","position":1,"cik":"0001604458","reported_name":"Bronstein Ben","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2017-06-12T21:07:19.000Z","date":"2017-06-08","kind":"grant","acquired":true,"shares":17776,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Exercisable with respect to 100% of the shares on the one-year anniversary of the grant date, provided that the Reporting Person provides continuous service as a member of the Board of Directors of the Issuer through the applicable vesting date."}],"balance_after":17776,"derivative":{"exercise_price":5.15,"expiration_date":"2027-06-07","underlying":"Common Stock","underlying_shares":17776},"source":{"system":"sec-edgar","filing":"0000899243-17-016105","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1341235/000089924317016105/doc4.xml","form_type":"4"}},{"id":4435528,"issuer":{"id":6839,"kind":"organization","name":"Aldeyra Therapeutics, Inc."},"owners":[{"id":39188,"kind":"person","name":"Bronstein Ben","position":1,"cik":"0001604458","reported_name":"Bronstein Ben","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-02-21T21:31:53.000Z","date":"2017-02-17","kind":"purchase","acquired":true,"shares":4444,"price":4.5,"value":19998.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents shares of common stock purchased by the Reporting Person in the Issuer's follow-on offering, which closed on February 17, 2017."}],"balance_after":16944,"source":{"system":"sec-edgar","filing":"0000899243-17-004753","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1341235/000089924317004753/doc4.xml","form_type":"4"}}]}